[N,N-Bis(2-pyridylmeth­yl)glycinato-κ(4) N,N′,N′′,O]dichloridoiron(III)–[N,N-bis­(2-pyridylmeth­yl)glycine-κ(4) N,N′,N′′,O]dichloridozinc(II) (1/1)

The title compound, [Fe(C(14)H(14)N(3)O(2))Cl(2)]·[ZnCl(2)(C(14)H(15)N(3)O(2))], is formulated as [Fe(III)(bpg)Cl(2)][Zn(II)Cl(2)(bpgH)], where bpg is the tetra­dentate ligand N,N-bis­(2-pyridylmeth­yl)glycine. The structure contains one crystallographically distinct complex with Fe(III) and Zn(II)...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Anne, McKenzie, Christine J., Bond, Andrew D.
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2009
Materias:
Metal-Organic Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972039/
https://www.ncbi.nlm.nih.gov/pubmed/21578707
http://dx.doi.org/10.1107/S1600536809051022
Descripción
Sumario:The title compound, [Fe(C(14)H(14)N(3)O(2))Cl(2)]·[ZnCl(2)(C(14)H(15)N(3)O(2))], is formulated as [Fe(III)(bpg)Cl(2)][Zn(II)Cl(2)(bpgH)], where bpg is the tetra­dentate ligand N,N-bis­(2-pyridylmeth­yl)glycine. The structure contains one crystallographically distinct complex with Fe(III) and Zn(II) atoms present in a 50:50 ratio in a single-atom site. The non-coordinated O atoms of the carboxyl groups of bpg meet across crystallographic inversion centres, forming O—H⋯O hydrogen bonds that include only one H atom per two complexes, consistent with the 1:1 disorder of Fe(III) and Zn(II).

Ejemplares similares